CrossRef Orlistat and ezetimibe could differently alleviate the high-fat diet-induced obesity phenotype by modulating the gut microbiota Jin Jin, Jiani Wang, Ruyue Cheng, Yan Ren, Zhonghua Miao, Yating Luo, Qingqing Zhou, Yigui Xue, Xi Shen, Fang He, Haoming Tian Frontiers in Microbiology.2022;[Epub] CrossRef N-linoleyltyrosine ameliorates high-fat diet-induced obesity in C57BL/6 mice via cannabinoid receptor regulation Zheng-yu Yang, Yi-ying Wu, Yi Zhou, Yun-qi Yang, Jia-hui Zhang, Tao He, Sha Liu Frontiers in Endocrinology.2022;[Epub] CrossRef Anti-obesity pharmacotherapy for treatment of pediatric type 2 diabetes: Review of the literature and lessons learned from adults Megan O
A 2023 review in Cells described these agents as promising therapies across cardiovascular, renal, neurodegenerative, and metabolic conditions, while noting that the relative contribution of direct cellular effects versus improved cardiometabolic regulation remains under investigation [4]
Medical Citation URL Wingrove P
Patients can track coverage updates through the insurance coverage checker as policies adapt to the changing pricing landscape
